Emergent BioSolutions Inc. (EBS) Q4 2025 Earnings Call Prepared Remarks Transcript
Source: SeekingAlpha
2026-02-26 23:58:01 ET
Emergent BioSolutions Inc. (EBS) Q4 2025 Earnings Call February 26, 2026 5:00 PM EST...
Read the full article on Seeking Alpha
For further details see:
Emergent BioSolutions Inc. (EBS) Q4 2025 Earnings Call Prepared Remarks Transcript
Emergent BioSolutions Inc.
NASDAQ: EBS
EBS Trading
5.6% G/L:
$8.67 Last:
75,900 Volume:
$8.64 Open:
EBS Latest News
April 16, 2026 04:05:00 pm
Emergent BioSolutions Successfully Refinances Term Loan, Amends Asset-backed Loan Facility and Increases Financial FlexibilityApril 16, 2026 04:05:00 pm
Emergent BioSolutions to Report First Quarter 2026 Financial Results on April 30, 2026EBS Stock Data
$592,950,394
50,839,325
1.42%
58
N/A
Pharmaceuticals
Healthcare
US
Gaithersburg
